Challenges in managing adherence in patients with cardiovascular disease (review)
https://doi.org/10.18699/SSMJ20240605
Abstract
Cardiovascular diseases (CVD) remain one of the main problems in most countries of the modern world. In this connection, maintaining adherence to the treatment and prevention of CVD is a priority in the fight against diseases of the cardiovascular system. According to the WHO, insufficient adherence to treatment is an urgent medical problem. Approximately 35 % of patients cancel taking medications within a year after an acute cardiovascular event, which leads to a threefold increase in the risk of complications. The purpose of the review is to highlight the problem of low adherence in the aspect of CVD and highlight the main methods of increasing adherence to treatment. This article reflects the main aspects of adherence management, considers the factors leading to a decrease in the level of disease control, identifies the causes of low adherence, and identifies methods for increasing adherence to treatment in patients with CVD.
About the Authors
Yu. S. Ignatova
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
Yulia S. Ignatova - candidate of medical sciences.
650002, Kemerovo, Academician Barbarash blvd., 6
Ya. I. Bryukhanov
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
Yaroslav I. Bryukhanov.
650002, Kemerovo, Academician Barbarash blvd., 6
T. B. Pecherina
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
Tamara B. Pecherina - doctor of medical sciences.
650002, Kemerovo, Academician Barbarash blvd., 6
O. L. Barbarash
Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical University of Minzdrav of Russia
Russian Federation
Russian Federation
Olga L. Barbarash - doctor of medical sciences, academician of the RAS.
650002, Kemerovo, Academician Barbarash blvd., 6; 650029, Kemerovo, Voroshilova st., 22a
References
1. Cardiovascular health for everyone. Available at: https://world-heart-federation.org [In Russian].
2. Healthcare in Russia. 2017: Stat. Sat. / Rosstat. Moscow, 2017. – 170 p. [In Russian].
3. Sabaté E., de Geest S. Adherence to long-term therapies management: a call for cardiovascular nursing managers and policymakers. Prog. Cardiovasc. Nurs. 2004;19(1):28–29. doi: 10.1111/j.0889-7204.2004.02896.x
4. Lukina Yu.V., Kutishenko N.P., Martsevich S.Yu. Treatment adherence: modern view on a well known issue. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2017;16(1):91–95. [In Russian]. doi: 10.15829/1728-8800-2017-1-91-95
5. WHO. Adherence to long-term therapies: evidence for action. WHO Library Cataloguing-in-Publication Data. Geneva: WHO, 2003.
6. Barbarash O.L., Petrova M.M., Chumakova G.A., Davidovich I.M., Trubnikova O.A., Kupriyanova T.V., Eremina O.V., Prokopenko S.V., Kaskaeva D.S., Demenko T.N. Cognitive disorders in cardiovascular diseases. Novosibirsk: Nauka, 2020. 232 p. [In Russian].
7. Lam W.Y., Fresco P. Medication adherence measures: an overview. Biomed.Res.Int. 2015;2015:217047. doi: 10.1155/2015/217047
8. Tanna S., Lawson G. Analytical chemistry for assessing medication adherence. Elsevier Inc., 2016, 142 p.
9. Frolova E.V., Ogorelysheva A.I., Spasenova E.S., Halilova T.R. Diary of self-monitoring of the patient as a way to increase adherence to the treatment of patients with chronic heart failure. Rossiyskiy semeynyy vrach = Russian Family Doctor. 2019;23(2):21–26. [In Russian]. doi: 10.17816/RFD2019221-26
10. Alili M., Vrijens B., Demonceau J., Evers S.M, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br. J. Clin. Pharmacol. 2016;82(1):268–279. doi: 10.1111/bcp.12942
11. Nguyen T., La Caze A., Cottrell N. What are validated self-report adherence scales really measuring? A systematic review. Br. J. Clin. Pharmacol. 2014;77(3):427–445. doi: 10.1111/bcp.12194
12. Abegaz T.M., Shehab A., Gebreyohannes E.A., Bhagavathula A.S., Elnour A.A. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4):e5641. doi: 10.1097/MD.0000000000005641
13. Lukina Yu.V., Kutishenko N.P., Martsevich S.Yu., Shepel’ R.N., Drapkina O.M. Methodological recommendations: “Adherence to drug therapy in patients with chronic non-communicable diseases. Addressing the problem in a number of clinical situations”. Profilakticheskaya meditsina = The Russian Journal of Preventive Medicine and Public Health. 2020;23(3-2):42–60. [In Russian]. doi: 10.17116/profmed20202303242
14. Rodriguez F., Maron D., Knowles J., Virani S.S., Lin S., Heidenreich P.A. Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease. JAMA Cardiol. 2017;2(1):47–54. doi: 10.1001/jamacardio.2016.4052
15. Sperber C., Samarasinghe S., Lomax G. An upper and lower bound of the Medication Possession Ratio. Patient Prefer. Adherence. 2017;11:1469–1478. doi: 10.2147/PPA.S136890
16. Barbarash O.L., Pecherina T.B. Modern ways to reduce mortality in myocardial infarction. What should be done? Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal. 2023;43(5):6–13. [In Russian)]. doi: 10.18699/SSMJ20230501
17. Rusu R.N., Ababei D.C., Stanciu G.D., Neamțu M., Macadan I., Lazăr C.I., Bild V. Adherence to treatment – reviewing methods of assessment and improvement. Farmacia. 2023;71(2):236–243. doi: 10.31925/farmacia.2023.2.2
18. Chang S., Lu I., Chen Y., Hsuan C.F., Lin Y.J., Chuang H.Y. Behavioral factors associated with medication nonadherence in patients with hypertension. Int. J. Environ. Res. Public Health. 2021;18(18):9614. doi: 10.3390/ijerph18189614
19. Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Klyuev D.A., Stepanyan L.N. Medication adherence in patients with cardiovascular disease: current view of the problem. Kachestvennaya klinicheskaya praktika = High-Quality Clinical Practice. 2019;(4):66–80. [In Russian]. doi: 10.1016/2588-0519-2019-4-66-80
20. Abbas H., Kurdi M., de Vries F., van Onzenoort H.A.W., Driessen J.H.M., Watfa M., Karam R. Factors associated with antihypertensive medication non-adherence: A cross-sectional study among Lebanese hypertensive adults. Patient Prefer. Adherence. 2020;14:663–673. doi: 10.2147/PPA.S238751
21. Dhar A., Barton D. Depression and the link with cardiovascular disease. Front. Psychiatry. 2016;7:33. doi: 10.3389/fpsyt.2016.00033
22. Spence S., March S., Donovana C. Social support as a predictor of treatment adherence and response in an open-access, self-help, internet-delivered cognitive behavior therapy program for child and adolescent anxiety. Internet Interv. 2019;18:100268. doi: 10.1016/j.invent.2019.100268
23. Lichtman J.H., Froelicher E.S., Blumenthal J.A., Carney R.M., Doering L.V., Frasure-Smith N., Freedland K.E., Jaffe A.S., Leifheit-Limson E.C., Sheps D.S., … American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations. Circulation. 2014;129(12):1350–1369. doi: 10.1161/CIR.0000000000000019
24. Hare D.L., Toukhsati S.R., Johansson P., Jaarsma T. Depression and cardiovascular disease: A clinical review. Eur. Hear. J. 2014;35:1365–1372. doi: 10.1093/eurheartj/eht462
25. Emdin C., Odutayo A., Wong C., Tran J., Hsiao A.J., Hunn B.H.M. Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am. J. Cardiol. 2016; 118(4):511–519. doi: 10.1016/j.amj-card.2016.05.041
26. Kessing D., Denollet J., Widdershoven J., Kupper N. Psychological determinants of heart failure self-care: systematic review and meta-analysis. Psychosom. Med. 2016;78(4):412–431. doi: 10.1097/PSY.0000000000000270
27. Gast A., Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst. Rev. 2019; 8(1):112. doi: 10.1186/s13643-019-1014-8
28. Biddle M., Moser D., Pelter M., Robinson S., Dracup K. Predictors of adherence to self-care in rural patients with heart failure. J. Rural Health. 2020;36(1):120–129. doi: 10.1111/jrh.12405
29. Gutierrez M., Sakulbumrungsil R. Factors associated with medication adherence of hypertensive patients in the Philippines: a systematic review. Clin. Hypertens. 2021;27(1):19. doi: 10.1186/s40885-021-00176-0
30. Uchmanowicz B., Chudiak A., Uchmanowicz I., Rosińczuk J., Froelicher E.S. Factors influencing adherence to treatment in older adults with hypertension. Clin. Interv. Aging. 2018;13:2425–2441. doi: 10.2147/CIA.S182881
31. Ho P.M., Lambert-Kerzner A., Carey E.P., Fahdi I.E., Bryson Ch.L., Melnyk S.D., Bosworth H.B., Radcliff T., Davis R., Mun H., … Giacco E.J.D. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern. Med. 2014;174(2):186–193. doi: 10.1001/jamainternmed.2013.12944
32. Khonsari S., Subramanian P., Chinna K., Latif L.A., Ling L.W., Gholami O. Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. Eur. J. Cardiovasc. Nurs. 2015;14(2):170–179. doi: 10.1177/1474515114521910
33. Al-Arkee S., Mason J., Lane D.A., Fabritz L., Chua W., Haque M.S., Jalal Z. Mobile apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis. J. Med. Internet Res. 2021;23(5):e24190. doi: 10.2196/24190
34. Peng Y., Wang H., Fang O., Xie L., Shu L., Sun W., Liu Q. Effectiveness of mobile applications on medication adherence in adults with chronic diseases: a systematic review and meta-analysis. J. Manag. Care Spec. Pharm. 2020;26(4):550–561. doi: 10.18553/jmcp.2020.26.4.550
35. Pérez-Jover V., Sala-González M., Guilabert M., Mira J.J. Mobile apps for increasing treatment adherence: systematic review. J. Med. Internet Res. 2019;21(6):e12505. doi: 10.2196/12505
36. Atreja A., Bellam N., Levy S.R. Strategies to enhance patient adherence: making it simple. Med-GenMed. 2005;7(1):4.
37. Gjesing A., Schou M., Torp-Pedersen C., Køber L., Gustafsson F., Hildebrandt P., Videbæk L., Wiggers H., Demant M., Charlot M., Gislasonet G.H. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care. Eur. J. Heart Fail. 2013;15(6):671–678. doi: 10.1093/eurjhf/hft011
38. Pourhabibi N., Mohebbi B., Sadeghi R., Shakibazadeh E., Sanjari M., Tol A., Yaseri M. Factors associated with treatment adherence to treatment among in patients with type 2 diabetes in Iran: A cross-sectional study. Front. Public Health. 2022;10:976888. doi: 10.3389/fpubh.2022.976888
39. Miller T.A. Health literacy and adherence to medical treatment in chronic and acute illness: A meta-analysis. Patient Educ. Couns. 2016;99(7):1079–1086. doi: 10.1016/j.pec.2016.01.020
Review
For citations:
Ignatova Yu.S., Bryukhanov Ya.I., Pecherina T.B., Barbarash O.L. Challenges in managing adherence in patients with cardiovascular disease (review). Сибирский научный медицинский журнал. 2024;44(6):48-56. (In Russ.) https://doi.org/10.18699/SSMJ20240605
Views:
703
Email this article 